Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Clinical trial NCT03701308 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03701308
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-28
- Primary completion
- 2024-10-01
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.